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Purpose: To investigate correlated factors on final visual acuity in conjunction with fluorescein angiography (FA) 
and optical coherence tomography (OCT) findings of chronic central serous chorioretinopathy (CSCR).
Methods: Twenty-four patients (36 eyes) with typical findings of chronic CSCR based on medical records, FA and 
OCT results were enrolled in this study. We investigated demographic findings, initial and final visual acuity (VA), 
and some typical findings of FA including the type of leakage pattern, the existence of a gravitational tract and an 
abnormal hyperfluorescent area centered on the fovea. We also investigated OCT findings to examine serous 
retinal detachment, outer photoreceptor layer (OPRL) preservation, continuity of the inner segment (IS) and the 
outer segment (OS) of the photoreceptor layer in case of macular attachment, and other typical findings. The con-
verted logarithm of the minimum angle of resolution VA was used to investigate the statistical correlation with 
these FA and OCT findings.
Results: An abnormal hyperfluorescent area within 1 macular photocoagulation study disc area on FA and cystoid 
degeneration on OCT were correlated with poor final VA of less than 20 / 40. However, the preserved OPRL and 
the continuity of IS / OS junction were correlated with a good final VA of 0.5 or more.
Conclusions: These specific findings could be associated with recurrent or persistent subretinal fluid and could be 
important parameters of decision for treatment.
Key Words: Chronic central serous chorioretinopathy, Fluorescein angiographic findings, Optical coherence 
tomography findings
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Central serous chorioretinopathy (CSCR) is characterized 
by serous retinal detachment (RD) with focal leakage at the 
level of the retinal pigment epithelium (RPE) [1,2]. Most of 
these cases resolve within four to six months, and a good fi-
nal visual acuity of more than 20 / 40 is observed in 90% of 
cases, although color vision and contrast sensitivity are often 
disturbed [3,4].
 CSCR shows bilateral involvement in 30%, 
recurrence in 30% to 50% and severe visual loss in 5% of pa-
tients due to its chronic course [5-9].
Chronic CSCR, which is also known as diffuse retinal pig-
ment epitheliopathy, is generally characterized by multifocal, 
irregularly distributed and often widespread RPE changes as-
sociated with varying degrees of low-grade leakage. This 
disease is often bilateral and occurs more frequently in eld-
erly patients. Chronic CSCR is the most severe form and in-
volves persistent or recurrent serous retinal detachment, RPE 
detachment, macular pigmentary change, gravitational tract, 
telangiectatic change of a retinal capillary, capillary non-
perfusion, subretinal fibrosis, neuroretinal degeneration, and 
secondary choroidal neovascularization [10-13].
CSCR can be diagnosed through biomicroscopic examina-
tion, fluorescein angiography (FA), optical coherence to-
mography (OCT), and indocyanine angiographic findings. 
These diagnostic tools supply reciprocal information and 
have helped further the understanding of the pathophysiol-
ogy of this disease and its treatment decisions [11,14-21].
Some reports exist regarding the factors that influence the 
final visual outcome of CSCR [3-5,12,18,22], but few reports 




Fig. 1. Subgroup of chronic central serous chorioretinop-
athy (CSCR). (A) Chronic active CSCR, (B) chronic 
non-active CSCR, and (C) recurrent CSCR, respectively.
junction with simultaneous findings of FA and OCT. The 
purpose of this study was to investigate correlated factors on 
final visual acuity in conjunction with the clinical, FA and 
OCT findings of chronic CSCR.
Materials and Methods
We enrolled 36 eyes of 24 patients with typical findings of 
chronic, recurrent CSCR among 121 patients who were diag-
nosed with CSCR based on medical records, FA and OCT 
from 2005 to 2007 at the Casey Eye Institute, Oregon Health 
and Science University.
The subgroups were defined as follows: Chronic CSCR in-
cluded findings of multifocal, irregularly distributed or wide-
spread RPE change with varying degrees of low-grade leak-
age on FA and an apparent history of recurrence or persistent 
symptoms of more than six months [23,24]. Chronic active 




Fig. 2. Quantification of an abnormal hyperfluorescent lesion within the 1 Macular Photocoagulation Study Disc Area (MPS 
DA) and circle with a radius of 3,000 μm centered on the fovea using image analysis software. 
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Fig. 3. Factors for investigation in optical coherence tomography findings. From (A) to (G) represents serous retinal detachment, intact outer 
photoreceptor layer with bulging on the retinal pigment cell (RPE) layer, intact and disrupted outer segment, inner segment junction of the pho-
toreceptor, cystoid degeneration, RPE detachment, irregularity of the RPE and choroidal band (undulation or thickness abnormality), 
respectively.
neurosensory RD, and chronic nonactive CSCR (CNACSCR) 
or sequelae of CSCR exhibited findings with no neuro-
sensory RD. Recurrent CSCR included findings with no se-
vere RPE change on FA compared with chronic CSCR and a 
leaking pattern consistent with acute CSCR but with an appa-
rent history of recurrence (Fig. 1).
We investigated demographic findings such as age, race, 
sex, time of first diagnosis of CSCR, initial and final visual 
acuity (VA), and changes of clinical findings throughout the 
period of this study.
We used the Zeiss FF3 (Carl Zeiss Meditec, Dublin, CA, 
USA) for FA and examined the central 30 degrees and the pe-
ripheral field when necessary. We investigated the type of 
leakage pattern and the existence of a gravitational tract and 
measured the area of abnormal hyperfluorescence, which in-
cluded any window defect, i.e., staining associated with 
low-grade leaking, except a hyperfluorescent area associated 
with focal leakage or RPE detachment. We also checked the YY Kim and CJ Flaxel. Factors Influencing the VA of Chronic CSCR
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Table 1. Initial demographic findings
Character No
Average age (yr) 53 (37-77)
Race                   Caucasian (23), Hispanic (1)
Sex                    Male (22), female (2)
Subgroup (eyes)        CACSCR (15) 
CNACSCR (16) 
RECSCR (5) 
Bilaterality             12 
                       Bilateral CACSCR (2)
                       Bilateral CNACSCR (3)
                       CACSCR + CNACSCR (5)
                       RECSCR + CNACSCR (2)
Unilaterality    12 
                       CACSCR (6)
                       CNACSCR (3)
                      RECSCR (3)
CACSCR = chronic active central serous chorioretinopathy; 
CNACSCR = chronic nonactive central serous chorioretinopathy; 
RECSCR = recurrent central serous chorioretinopathy. 
Initial logMAR VA
Fig. 4. Relationship of initial logarithm of the minimum angle of 
resolution (logMAR) visual acuity (VA) and final logMAR VA.
foveal involvement and measured the hyperfluorescent area 
within the 1 Macular Photocoagulation Study Disc Area 
(MPS DA) and a circle with a 3,000-μm radius centered on 
the fovea (Fig. 2). We used ANKA-ProView software (Topcon 
Medical Systems, Paramus, NJ, USA), which allows the cal-
culation of the area using pixel-size data based on image sen-
sor specifications and the magnification of the camera sys-
tem used to measure the hyperfluorescent area. The scale of 
the area was calculated with MPS DA.
We performed OCT (Stratus OCT, Carl Zeiss Meditec) to 
examine serous RD or RPE detachment, outer photoreceptor 
layer (OPRL) preservation in case of serous RD, and con-
tinuity of the inner segment (IS) and outer segment (OS) of 
the photoreceptor layer in case of macular attachment. We al-
so investigated the macular thickness, the change associated 
with the RPE-choroid band, and the change in the neuro-
sensory layer (Fig. 3). We converted the final Snellen VA to 
logarithm of the minimum angle of resolution (logMAR) VA 
to investigate the statistical correlation with FA, and OCT 
findings of the last follow-up visit.
Statistical analysis
We used univariate and multivariate analysis with the mixed 
effect method for correlation of VA of less than 20 / 40 and 
FA factors including foveal involvement, area of abnormal 
hyperfluorescence within 1 MPS DA and a circle with a 
3,000-μm radius centered on the fovea, existence of a grav-
itational tract, leakage pattern and central macula thickness 
by OCT. We also used Fisher’s exact test to analyze the cor-
relation of the final VA and OCT factors including existence 
of serous RD and PED, preservation of OPRL in serous RD, 
IS / OS continuity in macular attachment, abnormality of an 
RPE-choroid band, and existence of cystoid degeneration. 
Statistical significance was interpreted as p < 0.05.
Results
On initial examination, 15 eyes showed CACSCR; 22 of 
24 patients were male (Table 1). The period of CSCR history 
ranged from 10 months to 20 years. The initial average 
logMAR VA was 0.4, and 23 out of the 36 eyes showed a 
Snellen VA of 20 / 40 or more; 7 eyes were 20 / 200 or less. 
The final average logMAR was 0.41 and showed no stat-
istical change compared to the initial VA. At final examina-
tion, 24 of the 36 eyes showed a VA of 20 / 40 or more, and 7 
eyes were 20 / 200 or less. The average follow-up period was 
five months, and five eyes showed a decreased VA of more 
than 0.2 by logMAR VA, while three eyes showed an in-
creased VA of more than 0.2 by logMAR VA (Fig. 4). During 
the follow-up period, these changes were related with a new 
serous RD or a change of volume of serous fluid in all but two 
cases, one of which developed choroidal neovascularization 
(CNV) and the other recovered from the unexplained visual 
loss.
Focal-point leakage on FA occurred in 7 patients; 4 were 
initially diagnosed with recurrent CSCR (RECSCR) and 
three as CACSCR. The other 13 initially diagnosed CACSCR 
patients showed no apparent leaking points on FA but neuro-
sensory RD on OCT; this leakage pattern was not statistically 
correlated with the final VA of less than 20 / 40 (p > 0.05). 
Nine patients showed a gravitational tract in the inferior reti-
na and a positive correlation with the hyperfluorescence area 
in the circle of a 3,000-μm radius centered on the fovea (p < 
0.05) (Fig. 5) but no correlation with the final VA of less than 
20 / 40 (p > 0.05). Twenty-two eyes initially showed abnor-
mal hyperfluorescence in the fovea, but 24 eyes showed final 
involvement. At the final examinations, the abnormal hyper-Korean J Ophthalmol Vol.25, No.2, 2011
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Existence of gravitational tract
   No                                                       Yes
Fig. 5. The existence of a gravitational tract was compared with the 
area of abnormal hyperfluorescence within a circle with a 3,000-μm 
radius centered on the fovea using Wilcoxon’s rank sum test. These 
two variables were statistically correlated (p < 0.05). DA = disc 
area.  













Average logMAR VA 0.55 0.33 0.42 0.41
Central macular thickness (μm) 306 206 255 242 0.28
FA findings
   Abnormal hyperfluorescence
     
*Foveal involvement 11 11 2 24 0.003
     
*DA within 1MPS DA 0.65 DA 0.43 DA 0.2 DA 0.49 DA 0.0001
     
*DA within a 3,000-μm radius circle 4.5 DA 3.65 DA 0 DA 3.73 DA 0.01
   Gravitational tract 4 5 0   9 0.23
OCT findings
     
†Preserved outer photo receptor  9 2 11 0.02
     
†Inner and outer segment continuity 9   9 0.02
      Bulging on the RPE layer 6 0   6 0.13
     
*Irregularity of RPE choroid band 2 2 0   4 0.009
     
*Cystoid degeneration 3 6 0   9 0.001
      Sensory retinal detachment 12 2 14 0.14
      RPE detachment 2 2   4 0.53
CACSCR = chronic active central serous chorioretinopathy; CNACSCR = chronic nonactive central serous chorioretinopathy; RECSCR = 
recurrent central serous chorioretinopathy; VA = visual acuity; logMAR = logarithm of the minimum angle of resolution; FA = fluorescein 
angiography; DA = disc area; MPS = Macular Photocoagulation Study; OCT = optical coherence tomography; RPE = retinal pigment 
epithelium.
*Statistically significant correlation of final VA of less than 20 / 40; 
†Statistically significant correlation of final VA of 20 / 40 or more.
DA of abnomality within 1 MPS DA
Fig. 6. Area of abnormal hyperfluorescence within 1 Macular 
Photocoagulation Study Disc Area (MPS DA) centered on the fovea 
was highly correlated with final logarithm of the minimum angle of 
resolution (logMAR) visual acuity (VA) of more than 0.3 (equivalent 
to Snellen VA of less than 20 / 40) (p < 0.01). 
fluorescent area on FA was 0.65 DA and 4.5 DA within 1 
MPS DA and the circle of 3,000-μm radius, respectively, and 
differed according to the subgroup (Table 2). These three fac-
tors of foveal involvement, an abnormal hyperfluorescent 
area within 1 MPS DA and a circle with a 3,000-μm radius 
showed statistically significant correlations with a final VA 
of less than 20 / 40 in univariate analysis (p < 0.01). However, 
an abnormal hyperfluorescent area within 1 MPS DA cen-
tered on the fovea was the dominant factor having a statisti-
cally significant correlation with the final VA in multivariate 
analysis (p < 0.01) (Fig. 6).
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eyes had extramacular involvement and 3 eyes of the remain-
ing 12 eyes showed subtle serous fluid (SRF). During the fol-
low-up period, 3 of 5 eyes with RECSCR and 4 of 15 eyes 
with CACSCR showed a disappearance of serous fluid, 
which indicated an increased tendency for persistent SRF in 
CACSCR; however, this finding was inconclusive due to dif-
ferent follow-up periods. One patient showed new SRF at the 
final visit. We were not sure whether this case of SRF was re-
current or persistent because this finding could have changed 
during the follow-up period. The average macular thickness 
in CNACSCR was 206 μm at the final examination, but there 
were few extremely atrophic cases. One case showed 126 um 
central macular thickness (thinnest among all cases), and this 
patient had a diffuse hyperfluorescent area in the post pole 
(6.9 MPS DA) with suspected subretinal fibrosis and a VA of 
20 / 400. However, final central macular thickness was not 
statistically correlated with final VA. 
The signs associated with an RPE-choroid band were 
small bulging on the band in six eyes and an irregular change 
of thickness with undulation in four eyes at final examination 
(Fig. 2E and 2G). The latter findings were usually combined 
with CNV and cystoid degeneration or subretinal fibrotic 
changes and were statistically correlated with a final VA of 
less than 20 / 40 (p < 0.05). 
OPRL was seen in 17 of 20 eyes initially and in 11 of 14 
eyes finally (Table 2). Initially, most of the eyes showed an 
even profile appearance, but a granulated change was ob-
served in 2 eyes during the follow-up period (Fig. 2B). In 
contrast to the author’s expectations, no eyes showed any 
distinctive atrophic changes of OPRL in the state of neuro-
sensory RD, and 2 of the 3 eyes that showed no distinctive 
OPRL had severe cystoid degeneration. The preserved 
OPRL was correlated with the final VA of 0.5 or more (p < 
0.05).
The continuity of IS / OS on OCT was observed in 7 of 16 
eyes in CNACSCR initially and in 9 of 22 eyes finally. 
Among 7 eyes with initial serous RD in which SRF dis-
appeared during the follow-up period, only 2 eyes showed 
the continuity of IS / OS at the final visit. This visible con-
tinuity of IS / OS was statistically correlated with a final VA 
of 20 / 40 or more (p < 0.05). Five patients among the 7 pa-
tients who showed a final VA of 0.1 or less had severe cystoid 
degeneration on OCT. This sign was highly correlated with a 
final VA of 20 / 40 or less (p < 0.01) (Table 2).
Discussion
The major differences between this study and previous re-
ports [4,22-24] were the definition of the CSCR classi-
fication, follow-up period length and clinical factors eval-
uated for statistical analysis. We focused on clinical factors 
that influenced the final VA according to our defined criteria 
and the initial or final findings in a relatively short follow-up 
period.
The average age, bilaterality and predominance of male 
patients in our study were not different from previous epi-
demic reports [3,14,25-27]. The higher average age in this 
study compared with that of idiopathic CSCR was expected 
considering the chronic course of this disease. Five patients 
among the total 24 patients had more than a 15-year history 
of CSCR.
Abnormal hyperfluorecence on FA implied a previous epi-
sode of this disease, and this finding was observed in 43 to 
92% of cases in previous reports. This different rate is due to 
the varying selection of patients and follow-up period lengths 
[22-24]. Loo et al. [22] reported that this change was not cor-
related with the final VA, and Wong et al. [28] determined 
that this area had a tendency for a negative correlation with 
the final VA but showed no statistically significant 
difference.
 Our study found a statistically significant correla-
tion of the final VA and area of abnormal hyperfluorescence 
within 1 MPS DA centered on the fovea by FA. This discrep-
ancy could be caused by the fact that the previous report did 
not use a detailed quantitative method and did not analyze fo-
veal involvement, implying possible photoreceptor cell atro-
phy [12]. Although we could not conclude how long persis-
tent or recurrent SRF had influenced the amount of abnormal 
hyperfluorescent areas on FA, we did observe that a relatively 
short duration of SRF caused abnormal hyperfluorescence on 
FA. 
Inferior gravitational atrophic tract implicates previous se-
vere persistent SRF. In contrast to a previous report that 
showed a statistical correlation with a poor visual outcome 
[10], our study showed no correlation with final VA in the ab-
sence of combined macular pathologic findings such as CNV 
or cystoid degeneration. 
OCT can supply more information about the diagnosis and 
prediction of prognosis in CSCR [11,12,16-18]. In particular, 
OCT can show subtle SRF and cystoid degeneration that can-
not be easily found upon biomicroscopic examination, as 
well as changes of macular thickness. Thus OCT is specifi-
cally useful in the diagnosis of chronic CSCR that has subtle 
SRF and in cases where identification of a leaking area on FA 
is difficult. In addition, OCT can show small RPE detach-
ment and changes of the RPE-choroid layer and the outer 
photoreceptor layer [16-18].
Eight eyes with extramacular involvement of SRF were in-
itially identified in this study. This finding can occur in the 
recovery period but can also be a manifestation of an initial 
finding of chronic CSCR and may indicate new or persistent 
SRF despite a lack of symptoms. Bujarborua et al. [29] re-
ported that an asymptomatic eye can have SRF in 22% of pa-
tients who had history of CSCR, and Wang et al. [30] re-
ported that persistent SRF of more than four months duration 
can induce photoreceptor cell atrophy and poor visual out-
come even after absorption of SRF. Thus, chronic CSCR pa-
tients should be followed more frequently, despite no symptoms.
Loo et al. [22] reported that serous RD and RPE detach-
ment are correlated with a final VA of 0.5 or less. However, 
our study showed no statistical correlation of VA and RPE Korean J Ophthalmol Vol.25, No.2, 2011
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detachment, probably because only four patients had RPE 
detachment. This small number of patients with RPE detach-
ment could be explained by the limitations of six radial scans 
of OCT. This method can miss the all-RPE detachment un-
like en face OCT or spectral domain OCT, which can scan a 
wide area simultaneously [17]. The present study also 
showed no correlation of existent serous RD with a final VA 
of less than 20 / 40. These discrepancies with previous re-
ports could be due to the fact that our sample included many 
patients with extramacular SRF and subtle SRF in chronic 
cases [31]. However, preservation of OPRL on OCT in most 
patients with serous RD could be another explanation. 
Piccolino et al. [18] reported that patients with a well-pre-
served outer photoreceptor layer can sustain good VA despite 
serous RD and will have good visual prognosis after macula 
attachment. Our study also showed that one of the two factors 
with a good correlation with final VA of 20 / 40 or more was 
well-preserved OPRL on OCT. 
In contrast to experimental retinal detachment [32], long 
survival of outer photoreceptor cells in persistent SRF can be 
explained by the high concentration of oxygen and glucose in 
the SRF connected with the tissue fluid of choroids [33]. 
Clinically there have been controversies about the duration 
and survival of the photoreceptor layer. Wang et al. [30]. re-
ported that persistent SRF for more than four months can in-
duce photoreceptor cell atrophy and decrease the macular 
thickness, causing poor visual outcome, but Piccolino et al. 
[18] found that persistent SRF for more than one year can 
cause photoreceptor cell atrophy and granulated changes. 
Our study showed granulated change of OPRL in one patient 
who had persistent SRF for 10 months, but this patient 
showed a VA of 20 / 20. Periodic examination by OCT is re-
quired because symptom duration mainly depends on vague 
memory recall by the patients. 
Our study investigated the correlation of final VA of 20 / 40 
or more and the continuity of IS and OS on OCT and showed 
statistical significance. Although 8 of 15 eyes having a final 
VA of 20 / 40 or more among the 22 patients with final mac-
ula attachment showed continuity of IS / OS, none of the eyes 
having a final VA of less than 20 / 40 showed continuity. This 
result can be explained either by the misalignment of outer 
segments during the recovery process of macular attachment 
[34,35] or by the relatively low resolution of the Stratus OCT. 
We did not use spectral domain OCT, which can provide 
more detailed information about IS and OS junction. In the 
future, we expect that this OCT can supply more exact in-
formation on this relationship.
Among the seven patients with final VA of 0.1 or less, one 
patient developed CNV, another patient had severe macular 
atrophy with subretinal fibrosis and the rest had cystoid de-
generation, which showed a statistical correlation with VA of 
less than 20 / 40 and even 20 / 200 or less. The present study 
found four patients had irregular thickness and undulation of 
RPE-choroid hyperreflective band. Among these patients, 
apparent CNV occurred in one patient during the follow-up 
period, probable occult CNV was seen in another patient and 
cystoid degeneration was noted in two additional patients. 
We assumed that these OCT findings in chronic CSCR repre-
sented probable poor prognosis, suggesting the risk of CNV 
development. 
Iida et al. [12] reported that seven eyes with a VA of 20 / 200 
or less had cystoid degeneration, and this finding was corre-
lated with poor VA. The present study also showed a correla-
tion with poor final VA. Chronic foveal macular detachment, 
fluid accumulation in the inner retina and outer retina ische-
mia are the proposed mechanisms of this finding. In contrast 
to Iida’s results that showed a foveal RPE abnormality on FA 
only in four of seven patients with cystoid degeneration, the 
present study showed all five patients had foveal involve-
ment of abnormal hyperfluorescence by FA, implicating 
macular atrophy or RPE. The three remaining patients had a 
history of CSCR for more than 7 years, and two patients had 
a history of more than 20 years. There must be more efforts to 
elucidate the possible cause of cystoid degeneration aside 
from a long history of CSCR.
Photodynamic therapy has recently been used to treat 
chronic CSCR. This therapy can be used as an alternative 
method because conventional laser therapy cannot be applied 
in most cases of chronic CSCR; furthermore, this method ef-
fectively eliminates serous fluid [36-38]. Unfortunately, this 
therapy also has the drawbacks of possible neural retinal 
damage and development of choroidal neovascularization 
[39-41]. The ideal treatment for chronic CSCR should help 
promote survival of the photoreceptor layer by effective 
elimination of SRF without any other side effects. 
Neurotrophic factor [42,43] can be an adjuvant method for 
treatment of CSCR but requires more research.
In conclusion, preserved OPRL in cases of serous RD on 
OCT and continuity of IS / OS in case of macular attachment 
on OCT were correlated with a good final VA of 0.5 or more, 
and areas of abnormal hyperfluorescence within 1 MPS DA 
on FA and cystoid degeneration on OCT were correlated with 
a poor final VA of less than 20 / 40. All of these findings 
could be associated with recurrent or persistent SRF and 
could be important parameters of decision for treatment.
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